References

Al-Noor, M., A. Elazomi, A. Babiker and A.M. Babiker, 2016. Prevalence of hepatitis C virus antibodies among blood donors in Omdurman region in Sudan. J. Adv. Health Med. Sci., 2: 28-33.

Antolin, E., C. Comas, M. Torrents, A. Munoz, F. Figueras and M. Echevarria et al., 2001. The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. Ultrasound Obstetrics Gynecology, 17: 295-300.
CrossRef  |  PubMed  |  Direct Link  |  

Aune, I. and A. Moller, 2012. I want a choice, but I don't want to decide-A qualitative study of pregnant women’s experiences regarding early ultrasound risk assessment for chromosomal anomalies. Midwifery, 28: 14-23.
PubMed  |  Direct Link  |  

Bilardo, C.M., M.A. Muller, L. Zikulnig, M. Schipper and K. Hecher, 2001. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: Relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstetrics Gynecology, 17: 288-294.
CrossRef  |  Direct Link  |  

Borenstein, M., N. Persico, K.O. Kagan, A. Gazzoni and K.H. Nicolaides, 2008. Frontomaxillary facial angle in screening for trisomy 21 at 11+0 to 13+6 weeks. Ultrasound Obstetrics Gynecology, 32: 5-11.
CrossRef  |  Direct Link  |  

Borrell, A., A. Gonce, J.M. Martinez, V. Borobio and A. Fortuny et al., 2005. First‐trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers. Prenatal Diagnosis, 25: 901-905.
CrossRef  |  Direct Link  |  

Borrell, A., E. Antolin, D. Costa, M.T. Farre and J.M. Martinez et al., 1998. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy. Am. J. Obstetrics Gynecology, 179: 1612-1617.
Direct Link  |  

Borrell, A., J.M. Martinez, A. Seres, V. Borobio and V. Cararach et al., 2003. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy. Prenatal Diagnosis, 23: 921-926.
CrossRef  |  PubMed  |  Direct Link  |  

Borrell, A., V. Borobio, J.P. Bestwick and N.J. Wald, 2009. Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests. J. Med. Screening, 16: 112-118.
Direct Link  |  

Braithwaite, J.M., R.A. Kadir, T.A. Pepera, R.W. Morris and P.J. Thompson et al., 1996. Nuchal translucency measurement: Training of potential examiners. Ultrasound Obstetrics Gynecology, 8: 192-195.
CrossRef  |  PubMed  |  Direct Link  |  

Chang, T.C., 2006. Antenatal screening for Down syndrome in New Zealand: Time for a national screening policy?. Aust. N. Z. J. Obstetrics Gynaecology, 46: 92-96.
CrossRef  |  PubMed  |  Direct Link  |  

Collado, F., A. Bombard, V. Li, K. Julliard and L. Aptekar et al., 2005. Ethnic variation of fetal nasal bone length between 11-14 weeks gestation. Prenatal Diagnosis, 25: 690-692.
CrossRef  |  PubMed  |  Direct Link  |  

Comas, C., M.A. Rodriguez, M. Echevarria, J. Nicolau and B. Serra et al., 2009. Impact of ductus venosus assessment in screening Down syndrome protocols: An improved strategy in a Fetal Medicine Unit. Donald Sch. J. Ultrasound Obstetrics and Gynecology, 3: 10-17.
Direct Link  |  

Ekelund, C.K., O.B. Petersen, K. Sundberg, F.H. Pedersen and I. Vogel et al., 2012. Screening performance for trisomy 21 comparing first trimester combined screening and a first trimester contingent screening protocol including ductus venosus and tricuspid flow. Prenatal Diagnosis, 32: 783-788.
CrossRef  |  PubMed  |  Direct Link  |  

Favre, R., Y. Cherif, M. Kohler, A. Kohler and M.C. Hunsinger et al., 2003. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstetrics Gynecology, 21: 239-243.
CrossRef  |  Direct Link  |  

Florjanski, J., T. Fuchs, M. Zimmer, W. Homola and M. Pomorski et al., 2012. The role of ductus venosus Doppler flow in the diagnosis of chromosomal abnormalities during the first trimester of pregnancy. Adv. Clin. Exp. Med. Off. Organ Wroclaw Med. Univ., 22: 395-401.
Direct Link  |  

Ghaffari, S.R., A.R. Tahmasebpour, A. Jamal, S. Hantoushzadeh and L. Eslamian et al., 2012. First‐trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β‐hCG and PAPP‐A: A 5‐year prospective study. Ultrasound Obstetrics Gynecology, 39: 528-534.
CrossRef  |  PubMed  |  Direct Link  |  

Hecher, K., 2001. Assessment of ductus venosus flow during the first and early second trimesters: What can we expect?. Ultrasound Obstetrics Gynecology, 17: 285-287.
CrossRef  |  PubMed  |  Direct Link  |  

Hyett, J., G. Moscoso and K. Nicolaides, 1995. Increased nuchal translucency in trisomy 21 fetuses: Relationship to narrowing of the aortic isthmus. Hum. Reprod., 10: 3049-3051.
PubMed  |  Direct Link  |  

Hyett, J., G. Moscoso, G. Papapanagiotou, M. Perdu and K.H. Nicolaides, 1996. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 1l-13 weeks of gestation. Ultrasound Obstetrics Gynecology, 7: 245-250.
CrossRef  |  PubMed  |  Direct Link  |  

Hyett, J.A., G. Moscoso and K.H. Nicolaides, 1995. First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21. Am. J. Obstetrics Gynecology, 172: 1411-1413.
Direct Link  |  

Ilayasu, Z., W.H. Gilmour and D.H. Stone, 2002. Prevalence of Down’s syndrome in Glasgow, the growing impact of prenatal diagnosis in young mothers. Health Bull. (Ednb), 60: 20-26.

Kagan, K.O., I. Staboulidou, J. Cruz, D. Wright and K.H. Nicolaides, 2010. Two‐stage first‐trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstetrics Gynecology, 36: 542-547.
CrossRef  |  PubMed  |  Direct Link  |  

Kittichottipanich, B., U. Yingpaiboonsook, P. Somsauy and S. Kositwon, 2016. Model of health promotion for reducing risky behaviors of preterm birth in teenage pregnancy. Intl. J. Health Med. Sci., 2: 20-26.
Direct Link  |  

Maiz, N., C. Valencia, E.E. Emmanuel, I. Staboulidou and K.H. Nicolaides, 2008. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation. Obstetrics Gynecology, 112: 598-605.
PubMed  |  Direct Link  |  

Maiz, N., C. Valencia, K.O. Kagan, D. Wright and K.H. Nicolaides, 2009. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstetrics Gynecology, 33: 512-517.
CrossRef  |  PubMed  |  Direct Link  |  

Maiz, N., D. Wright, A.F.A. Ferreira, A. Syngelaki and K.H. Nicolaides, 2012. A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11-13 weeks gestation. Fetal Diagnosis Therapy, 31: 221-229.
PubMed  |  Direct Link  |  

Maiz, N., K.O. Kagan, Z. Milovanovic, E. Celik and K.H. Nicolaides, 2008. Learning curve for Doppler assessment of ductus venosus flow at 11+0 to 13+6 weeks gestation. Ultrasound Obstetrics Gynecology, 31: 503-506.
CrossRef  |  PubMed  |  Direct Link  |  

Matias, A., C. Gomes, N. Flack, N. Montenegro and K.H. Nicolaides, 1998. Screening for chromosomal abnormalities at 10-14 weeks: The role of ductus venosus blood flow. Ultrasound Obstetrics Gynecology, 12: 380-384.
CrossRef  |  PubMed  |  Direct Link  |  

Mavrides, E., S. Sairam, B. Hollis and B. Thilaganathan, 2002. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus. BJOG. Intl. J. Obstetrics Gynaecology, 109: 1015-1019.
CrossRef  |  PubMed  |  Direct Link  |  

Morris, J.K., D.E. Mutton and E. Alberman, 2002. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J. Med. Screening, 9: 2-6.
PubMed  |  Direct Link  |  

Munoz‐Cortes, M., M. Arigita, G. Falguera, A. Seres and D. Guix et al., 2012. Contingent screening for down syndrome completed in the first trimester: A multicenter study. Ultrasound Obstetrics Gynecology, 39: 396-400.
CrossRef  |  PubMed  |  Direct Link  |  

Murta, C.G., A.O.N.F. Moron, M.A.R.A. Avila and C.P. Weiner, 2002. Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy. Fetal Diagnosis Therapy, 17: 308-314.
PubMed  |  Direct Link  |  

Nicolaides, K.H., 2004. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am. J. Obstetrics Gynecol., 191: 45-67.
CrossRef  |  

Nicolaides, K.H., K. Spencer, K. Avgidou, S. Faiola and O. Falcon, 2005. Multicenter study of first‐trimester screening for trisomy 21 in 75 821 pregnancies: Results and estimation of the potential impact of individual risk‐orientated two‐stage first‐trimester screening. Ultrasound Obstetrics Gynecology, 25: 221-226.
CrossRef  |  Direct Link  |  

Prefumo, F., F. Sethna, S. Sairam, A. Bhide and B. Thilaganathan, 2005. First-trimester ductus venosus, nasal bones and Down syndrome in a high-risk population. Obstetrics Gynecology, 105: 1348-1354.
PubMed  |  Direct Link  |  

Ritter, S., H. Jorn, C. Weiss and W. Rath, 2004. Importance of ductus venosus Doppler assessment for fetal outcome in cases of intrauterine growth restriction. Fetal Diagnosis Therapy, 19: 348-355.
PubMed  |  Direct Link  |  

Sainz, J.A., R. Serrano, C. Borrero and E. Turmo, 2012. First trimester contingent test as a screening method for Down’s syndrome: A prospective study in the general population. J. Maternal Fetal Neonatal Med., 25: 2221-2224.
Direct Link  |  

Slack, C., K. Lurix, S. Lewis and L. Lichten, 2006. Prenatal genetics: The evolution and future directions of screening and diagnosis. J. Perinatal Neonatal Nurs., 20: 93-97.
PubMed  |  Direct Link  |  

Sonek, J. and K. Nicolaides, 2010. Additional first-trimester ultrasound markers. Clin. Lab. Med., 30: 573-592.
CrossRef  |  

Souka, A.P., E. Krampl, S. Bakalis, V. Heath and K.H. Nicolaides, 2001. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstetrics Gynecology, 18: 9-17.
CrossRef  |  Direct Link  |  

Spencer, K., V. Heath, E.A. Sheikhah, C.Y.T. Ong and K.H. Nicolaides, 2005. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: A study of Oriental, Asian and Afro‐Caribbean populations. Prenatal Diagnosis, 25: 365-369.
CrossRef  |  PubMed  |  Direct Link  |  

Timmerman, E., O.K. Rengerink, E. Pajkrt, B.C. Opmeer and V.D.J.A.M. Post et al., 2010. Ductus venosus pulsatility index measurement reduces the false‐positive rate in first‐trimester screening. Ultrasound Obstetrics Gynecology, 36: 661-667.
CrossRef  |  PubMed  |  Direct Link  |  

Toyama, J.M., M.L. Brizot, A.W. Liao, L.M. Lopes and R.M.Y. Nomura et al., 2004. Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome. Ultrasound Obstetrics Gynecology, 23: 341-345.
CrossRef  |  Direct Link  |  

Wald, N.J., A. Kennard, J.W. Densem, H.S. Cuckle and T. Chard et al., 1992. Antenatal maternal serum screening for Down’s syndrome: Results of a demonstration project. BMJ., 305: 391-394.
PubMed  |  Direct Link  |  

Wald, N.J., A.K. Hackshaw, J. Walters, A.M. Mackinson and C. Rodeck et al., 2003. First and second trimester antenatal screening for Down's syndrome: The results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J. Med. Screening, 10: 56-104.
Direct Link  |  

Wald, N.J., J.P. Bestwick and A. Borrell, 2012. Adding ductus venosus blood flow as a categorical variable to the Combined and Integrated tests in Down’s syndrome screening. J. Med. Screening, 19: 49-50.
PubMed  |  Direct Link  |  

Wald, N.J., J.W. Densen, L. George, S. Muthrishna and P.G. Knight, 1997. Prenatal screening for Down’s syndrome using inhibin A as a serum marker. Prenat Diagn., 17: 285-920.

Whiting, P.F., M.E. Weswood, A.W. Rutjes, J.B. Reitsma and P.N. Bossuyt et al., 2006. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC. Med. Res. Method., 6: 1-8.
CrossRef  |  Direct Link  |  

Zoppi, M.A., M. Putzolu, R.M. Ibba, M. Floris and G. Monni, 2002. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagnosis Therapy, 17: 52-57.
PubMed  |  Direct Link  |  

Zosmer, N., V.L. Souter, C.S.Y. Chan, I.C. Huggon and K.H. Nicolaides, 1999. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. BJOG. Intl. J. Obstetrics Gynaecology, 106: 829-833.
CrossRef  |  Direct Link  |